伊梅格林在2型糖尿病中对胰岛素分泌和敏感性的双重作用
Tsubasa Tajima1, Hideyoshi Kaga1, Naoaki Ito1
1Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
Diabetes, obesity & metabolism
|January 6, 2026
概括
伊梅格林在2型糖尿病中显著改善血糖控制,通过增强多种组织的胰岛素分泌和敏感性. 这种新的口服低血糖剂为控制血糖水平提供了一个有前途的治疗选择.
科学领域:
- 内分泌学 在内分泌学.
- 代谢过程中的代谢.
- 药理学 药理学是指药理学的学科.
背景情况:
- 伊梅格林是治疗2型糖尿病的口服降糖剂,临床前有双重作用的证据.
- 它对人体组织特异性胰岛素敏感性和葡萄糖运动学的影响尚不清楚.
研究的目的:
- 研究伊梅格林对日本2型糖尿病患者葡萄糖代谢,胰岛素分泌和组织特异性胰岛素敏感性的影响.
主要方法:
- 一项为期20周的单臂干预研究,涉及22名患有2型糖尿病的日本男性.
- 使用双标志物和高胰岛素-高血糖的口服葡萄糖耐受性测试 (OGTT).
- 在基线和随访点评估葡萄糖动力学,胰岛素分泌,胰岛素敏感性和胰岛素清除.
主要成果:
- 伊梅格林在OGTT期间显著降低了20周的曲线下的葡萄糖面积 (AUC),效果早在1周就出现了.
- 改善主要是由于口服葡萄糖出现率下降.
- 胰岛素分泌指数增加,研究显示,骨肌肉,肝脏和脂肪组织的胰岛素敏感性增加,胰岛素清除率增加.
结论:
- 伊梅格林有效地改善了人类多种组织中的胰岛素分泌和胰岛素敏感性.
- 提供了全面的证据支持imeglimin在2型糖尿病管理中的治疗潜力.
相关概念视频
Glucagon-like Receptor Agonists
836
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
836
Oral Hypoglycemic Agents: Glinides
593
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
593
Dipeptidyl Peptidase 4 Inhibitors
575
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
575
Oral Hypoglycemic Agents: Biguanides and Glitazones
581
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
581
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.2K
Hormones Regulating Blood Glucose
6.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.4K


